rs367799017
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PP2PP3_StrongPP5
The NM_001267550.2(TTN):āc.55269G>Cā(p.Lys18423Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000868 in 1,612,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.55269G>C | p.Lys18423Asn | missense_variant, splice_region_variant | 284/363 | ENST00000589042.5 | |
TTN-AS1 | NR_038272.1 | n.3917+1335C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.55269G>C | p.Lys18423Asn | missense_variant, splice_region_variant | 284/363 | 5 | NM_001267550.2 | P1 | |
TTN-AS1 | ENST00000659121.1 | n.502+4321C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151848Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000806 AC: 2AN: 248246Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134680
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460624Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726570
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151848Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74130
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2023 | Alters the last nucleotide of the exon and is predicted to destroy the splice donor site and result in aberrant splicing, although in the absence of functional evidence the actual effect of this sequence change is unknown; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 28, 2012 | The Lys15855Asn variant (TTN) has not been previously reported in the literature . This variant has been identified by our laboratory in one proband with HCM. Th is variant has also been identified in 1/6608 European American chromosomes from a broad population sequenced by the NHLBI Exome Sequencing Project (http://evs. gs.washington.edu/EVS/). This frequency is too low to exclude a role in disease as this could represent a presymptomatic individual. This variant is located one base pair from the 5' splice region. Computational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) predict that it m ay impact the protein and may also alter splicing, though this information is no t predictive enough to determine pathogenicity. In summary, the available data i s consistent with a pathogenic role but is insufficient to rule out a benign rol e. Additional studies are needed to fully assess the clinical significance of th is variant. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 18423 of the TTN protein (p.Lys18423Asn). This variant also falls at the last nucleotide of exon 284, which is part of the consensus splice site for this exon. This variant is present in population databases (rs367799017, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with TTN-related conditions. ClinVar contains an entry for this variant (Variation ID: 47103). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant is located in the A band of TTN (PMID: 25589632). Variants in this region may be relevant for cardiac or neuromuscular disorders (PMID: 25589632, 23975875). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at